viernes, 26 de julio de 2013

FDA Puts Strict Limits on Oral Ketoconazole Use

July 26, 2013  
  SILVER SPRING, Md. -- Oral ketoconazole (Nizoral) should never be used as first-line therapy for any fungal infection because of the risk of liver toxicity and interactions with other drugs, the FDA said Friday


No hay comentarios:

Publicar un comentario